Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus
Clinical trial NCT06532578 · COMPLETED
Trial details
- NCT number
- NCT06532578
- Sponsor
- Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-13
- Primary completion
- 2025-12-15
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.